CRNX
Crinetics Pharmaceuticals Inc
85.00$
+0.0%
vs. previous close
Closing price · As of: Sep 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 98.1% | 97.2% | 97.2% | 94.6% | 96.8% | 98.2% | 98.0% | 90.4% | 95.9% | 92.3% | |
| 96.5% | 91.0% | 26.2% | 30.9% | 50.7% | 57.2% | 9.3% | 8.6% | 18.4% | 8.9% | |
| 96.5% | 91.0% | 95.6% | 90.8% | 93.2% | 95.1% | 95.0% | 87.9% | 94.4% | 90.5% | |
| 0.6% | 4.7% | 0.9% | 1.1% | 1.0% | 0.6% | 0.7% | 1.5% | 0.6% | 0.1% | |
| 0.8% | 0.9% | – | -1.1% | -1.0% | -0.6% | – | – | 0.0% | 0.2% | |
| 1.8% | 2.6% | 2.5% | 5.0% | 3.0% | 1.3% | 1.4% | – | – | – | |
| 149.2% | 196.3% | 6.5% | 10.2% | 7.9% | 5.4% | 10.2% | 15.1% | 7.7% | 12.6% | |
| 7.1% | 5.8% | 4.6% | 6.4% | 5.7% | 4.6% | 7.9% | 6.9% | 4.2% | 7.5% | |
| 0.4% | – | – | 0.6% | 0.9% | 0.3% | 0.3% | 0.7% | 0.5% | 0.6% | |
| 2.7% | 2.6% | 0.8% | 2.1% | 1.9% | 1.2% | 2.0% | 1.0% | 0.4% | 2.0% | |
| 1.3% | – | – | – | – | – | – | – | – | – | |
| -49.2% | -96.3% | -25.3% | 89.8% | 92.1% | 94.6% | 89.8% | 84.9% | 92.3% | 87.4% | |
| -56.4% | -104.3% | -25.3% | -71.9% | -91.4% | -78.4% | -124.7% | -102.9% | -66.4% | -124.8% | |
| 110.2% | 89.0% | 7.1% | 18.5% | 16.6% | 10.9% | 14.8% | 9.1% | 5.6% | 8.3% |
Data as of: September 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.